After the prostate gland is surgically removed, the primary source of prostate-specific antigen (PSA) is gone. Consequently, blood levels of PSA drop rapidly. In a successful total prostatectomy, the level typically falls below standard detection limits, reaching an undetectable baseline within about six weeks.
Why PSA levels drop quickly
PSA is a protein produced almost exclusively by the prostate gland. Once the gland is excised, the body no longer produces significant amounts of this antigen. The half-life of PSA in the bloodstream is short, approximately two to three days. This means that any PSA remaining in the blood after surgery is cleared by the liver and kidneys quickly. Most men see their levels plummet to undetectable levels within a month or two of the procedure.
What counts as undetectable
Standard laboratory assays usually set the detection threshold at 0.1 ng/mL. A reading below this value is generally considered undetectable and is the expected result after a complete prostatectomy. However, modern ultrasensitive tests can detect much lower concentrations, sometimes down to 0.001 ng/mL. If a test reports a value like 0.02 ng/mL, it is technically detectable but still within the range often seen in men with no active cancer or significant residual tissue.
Residual tissue and small readings
Even after a careful surgery, microscopic islands of benign prostate tissue can sometimes remain. These remnants may be located near the bladder neck or in the surrounding fat. If these cells are still active, they can produce small amounts of PSA. This results in a low, stable reading that does not necessarily indicate cancer. Clinicians look at the trend over time rather than reacting to a single low number. A flat line near zero is expected; a steady upward trend requires further investigation.
Monitoring for recurrence
The main purpose of checking PSA after prostate removal is to detect if any cancer cells remain or return. If microscopic cancer was present at the edges of the removed gland (positive surgical margins), the risk of a rising PSA is higher. Doctors typically monitor serial blood draws to establish a pattern. A biochemical recurrence is often defined as two consecutive rising PSA levels above a certain threshold, though this can vary by clinic. Early detection allows for timely treatment if needed.
When to worry about rising levels
A single low but detectable PSA level is usually not a cause for alarm. However, a consistent rise over several months suggests that cells producing PSA are present and multiplying. This could be due to benign tissue or cancer. Advanced imaging, such as PSMA PET scans, is typically used only when PSA levels cross specific clinical thresholds, as very low levels may not show up on scans. Regular follow-up with a urologist is essential to interpret these numbers in the context of the original pathology report.